Syneos Health Inc. (SYNH)
Syneos Health Statistics
Share Statistics
Syneos Health has 103.72M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 103.72M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 103.27M |
| Failed to Deliver (FTD) Shares | 772 |
| FTD / Avg. Volume | 0.06% |
Short Selling Information
The latest short interest is 6.76M, so 6.52% of the outstanding shares have been sold short.
| Short Interest | 6.76M |
| Short % of Shares Out | 6.52% |
| Short % of Float | 8.23% |
| Short Ratio (days to cover) | 5.94 |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is null. Syneos Health's PEG ratio is 0.
| PE Ratio | 0 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Syneos Health.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0, with a Debt / Equity ratio of 0.
| Current Ratio | 0 |
| Quick Ratio | 0 |
| Debt / Equity | 0 |
| Debt / EBITDA | 4.14 |
| Debt / FCF | - |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $187.47K |
| Profits Per Employee | $9.26K |
| Employee Count | 28,768 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 48.07M |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 0% in the last 52 weeks. The beta is 1.58, so Syneos Health's price volatility has been higher than the market average.
| Beta | 1.58 |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 42.63 |
| 200-Day Moving Average | 39.49 |
| Relative Strength Index (RSI) | 72.61 |
| Average Volume (20 Days) | 1.32M |
Income Statement
In the last 12 months, Syneos Health had revenue of 5.39B and earned 266.5M in profits. Earnings per share was 2.57.
| Revenue | 5.39B |
| Gross Profit | 1.25B |
| Operating Income | 403.19M |
| Net Income | 266.5M |
| EBITDA | 699.99M |
| EBIT | 395.35M |
| Earnings Per Share (EPS) | 2.57 |
Balance Sheet
The company has 112M in cash and 2.9B in debt, giving a net cash position of -2.79B.
| Cash & Cash Equivalents | 112M |
| Total Debt | 2.9B |
| Net Cash | -2.79B |
| Retained Earnings | 167.69M |
| Total Assets | 8.08B |
| Working Capital | 324.6M |
Cash Flow
In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0.
| Operating Cash Flow | 0 |
| Capital Expenditures | 0 |
| Free Cash Flow | 0 |
| FCF Per Share | 0 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | 7.48% |
| FCF Margin | n/a |
Dividends & Yields
SYNH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for SYNH.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 1.44 |
| Piotroski F-Score | 7 |